Ratio de margen de beneficio operativo
desde 2019
Cálculo
Shockwave Medical Inc., ratio de margen de beneficio operativo, tendencias a largo plazocálculo
| Ratio de margen de beneficio operativo | = | 100 | × | Ingresos (pérdidas) de operaciones1 | ÷ | Ingresos1 | |
|---|---|---|---|---|---|---|---|
| 31 dic. 2023 | 21.79% | = | 100 | × | 159,093) | ÷ | 730,230) |
| 31 dic. 2022 | 25.35% | = | 100 | × | 124,134) | ÷ | 489,733) |
| 31 dic. 2021 | -0.37% | = | 100 | × | (871) | ÷ | 237,146) |
| 31 dic. 2020 | -96.86% | = | 100 | × | (65,663) | ÷ | 67,789) |
| 31 dic. 2019 | -120.76% | = | 100 | × | (51,839) | ÷ | 42,927) |
Basado en los informes: 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31).
1 US$ en miles
Comparación con la competencia
Shockwave Medical Inc., ratio de margen de beneficio operativo, tendencias a largo plazo, comparación con los competidores
| Shockwave Medical Inc. | Abbott Laboratories | Cigna Group | CVS Health Corp. | Humana Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|---|
| 31 dic. 2023 | 21.79% | 16.15% | 4.40% | 3.85% | 3.81% | 24.80% | 17.56% | 8.80% |
| 31 dic. 2022 | 25.35% | 19.16% | 4.69% | 2.41% | 4.11% | 25.35% | 18.15% | 8.83% |
| 31 dic. 2021 | -0.37% | 19.56% | 4.60% | 4.54% | 3.80% | 31.89% | 14.89% | 8.40% |
| 31 dic. 2020 | -96.86% | 15.48% | 5.12% | 5.19% | 6.56% | 24.09% | 16.57% | 8.76% |
| 31 dic. 2019 | -120.76% | 14.21% | 5.31% | 4.69% | 4.96% | 30.69% | 20.51% | 8.19% |
Basado en los informes: 10-K (Fecha del informe: 2023-12-31), 10-K (Fecha del informe: 2022-12-31), 10-K (Fecha del informe: 2021-12-31), 10-K (Fecha del informe: 2020-12-31), 10-K (Fecha del informe: 2019-12-31).